Inhibition of ROCK ameliorates pulmonary fibrosis by suppressing M2 macrophage polarisation through phosphorylation of STAT3
Author:
Affiliation:
1. Laboratory of Aging Research and Cancer Drug Target, State Key Laboratory of Biotherapy, National Clinical Research Center for Geriatrics, West China Hospital Sichuan University Chengdu Sichuan PR China
Publisher
Wiley
Subject
Molecular Medicine,Medicine (miscellaneous)
Link
https://onlinelibrary.wiley.com/doi/pdf/10.1002/ctm2.1036
Reference92 articles.
1. What have we learned from basic science studies on idiopathic pulmonary fibrosis;Yanagihara T;Eur Respir Rev,2019
2. What Differentiates Normal Lung Repair and Fibrosis?: Inflammation, Resolution of Repair, and Fibrosis
3. Nintedanib and Pirfenidone. New Antifibrotic Treatments Indicated for Idiopathic Pulmonary Fibrosis Offer Hopes and Raises Questions
4. Somogyi V Chaudhuri N Torrisi SE Kahn N Muller V Kreuter M. The therapy of idiopathic pulmonary fibrosis: what is next?Eur Respir Rev. 2019;28:190021.
5. Rho/ROCK pathway and neural regeneration: a potential therapeutic target for central nervous system and optic nerve damage;Tan HB;Int J Ophthalmol,2011
Cited by 7 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Unraveling the interplay between vital organelle stress and oxidative stress in idiopathic pulmonary fibrosis;Biochimica et Biophysica Acta (BBA) - Molecular Cell Research;2024-03
2. Enantiomer-Dependent Supramolecular Immunosuppressive Modulation for Tissue Reconstruction;ACS Nano;2024-02-02
3. Tissue fibrosis induced by radiotherapy: current understanding of the molecular mechanisms, diagnosis and therapeutic advances;Journal of Translational Medicine;2023-10-09
4. Monocytes and macrophages: emerging mechanisms and novel therapeutic targets in pulmonary fibrosis;American Journal of Physiology-Cell Physiology;2023-10-01
5. Application and Study of ROCK Inhibitors in Pulmonary Fibrosis: Recent Developments and Future Perspectives;Journal of Medicinal Chemistry;2023-03-20
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3